For the quarter ending 2025-09-30, CLOV made $496,650K in revenue. -$24,083K in net income. Net profit margin of -4.85%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Total revenues | 496,650 | 477,620 | 341,943 | 330,986 |
| Net medical claims incurred | 423,473 | 377,992 | 254,103 | 249,774 |
| Salaries and benefits | 48,195 | 61,309 | 60,980 | 54,995 |
| General and administrative expenses | 48,953 | 48,484 | 48,428 | 35,201 |
| Depreciation and amortization | 406 | 394 | 331 | 339 |
| Restructuring (recoveries) costs | 0 | 0 | 177 | -538 |
| Total operating expenses | 521,027 | 488,179 | 364,018 | 339,771 |
| Loss from continuing operations | -24,377 | -10,559 | -22,075 | -8,785 |
| Change in fair value of warrants | 0 | 19 | 11 | - |
| Loss on investment | 0 | 0 | -117 | - |
| Net loss from continuing operations | -24,377 | -10,578 | -22,325 | -8,785 |
| Net (loss) income from discontinued operations | 0 | 0 | 1,695 | -370 |
| Net loss | -24,377 | -10,578 | -20,631 | -9,155 |
| Net unrealized gain on available-for-sale investments | 294 | 251 | -1,313 | 3,111 |
| Comprehensive loss | -24,083 | -10,327 | -21,944 | -6,044 |
| Basic weighted average number of class a and class b common shares and common share equivalents outstanding (in shares) | 512,743,521 | 509,043,210 | -243,822,230 | 490,180,103 |
| Diluted weighted average number of class a and class b common shares and common share equivalents outstanding (in shares) | 512,743,521 | 509,043,210 | -247,670,664 | 490,180,103 |
CLOVER HEALTH INVESTMENTS, CORP. DE (CLOV)
CLOVER HEALTH INVESTMENTS, CORP. DE (CLOV)